Clinical Trials on Resectable

Total 1472 results

Massachusetts General Hospital

Terminated

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Resectable Intrahepatic Cholangiocarcinoma | Unresectable Intrahepatic Cholangiocarcinoma

United States
University of Arkansas

Not yet recruiting

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Borderline Resectable/Unresectable Pancreatic Cancer | Non Metastatic Pancreatic Cancer
The Netherlands Cancer Institute
Agenus Inc.

Recruiting

Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (NEOASIS)

Resectable MMR-deficient Solid Tumors | Resectable MMR-proficient Solid Tumors

Netherlands
City of Hope Medical Center
National Cancer Institute (NCI); Genentech, Inc.

Recruiting

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Locally Advanced Skin Squamous Cell Carcinoma | Unresectable Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Not yet recruiting

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Metastatic Osteosarcoma | Localized Osteosarcoma | Unresectable Osteosarcoma | Resectable Osteosarcoma
Sun Yat-sen University

Recruiting

Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma

Resectable Mucosal Melanoma

China
Zhejiang University

Recruiting

HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation

Borderline Resectable Pancreatic Adenocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

Non-Resectable Pancreas Carcinoma

China
Ji Yongling

Not yet recruiting

Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC (FAIR)

Resectable Esophageal Cancer

China
Theodor Bilharz Research Institute

Completed

New Technique of End-to-Side Two-Layered Duct-to-Mucosa Pancreaticojejunostomy With Omental Wrapping and Glue (Glubran 2) During Laparoscopic Whipple Operation

Periampullary Carcinoma Resectable

Egypt
University of California, San Francisco

Not yet recruiting

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable | Unresectable Hepatocellular Carcinoma | Hepatocellular Cancer

United States
Lawson Health Research Institute
London Health Sciences Foundation

Not yet recruiting

Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma (ANSR-PDAC)

Borderline Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenocarcinoma
Smartwise Sweden AB

Not yet recruiting

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Pancreatic Cancer Non-resectable

Sweden
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Pancreatic Cancer Non-resectable
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) (SPLENDID)

Pancreatic Cancer Resectable | Pancreatectomy

Netherlands, Norway, Japan, Sweden, China, Greece, Italy, Spain
Zhejiang Cancer Hospital

Active, not recruiting

Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

Pancreatic Cancer Non-resectable

China
Galera Therapeutics, Inc.

Terminated

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

Unresectable Pancreatic Cancer | Borderline Resectable Pancreatic Cancer | SBRT

United States, France, United Kingdom, Canada
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Hepatocellular Carcinoma Resectable

China
Helsinki University Central Hospital
Oulu University Hospital

Not yet recruiting

Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer (LEFT-PANC)

Pancreatic Cancer Resectable

Finland
Ohio State University Comprehensive Cancer Center

Recruiting

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Resectable Lung Non-Small Cell Carcinoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Specimens From Young Patients With Neuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Ganglioneuroblastoma

United States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
National Cancer Institute (NCI)

Completed

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Histologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic Ca

United States
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University; American Association for... and other collaborators

Recruiting

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma and other conditions

United States
Peking University First Hospital

Enrolling by invitation

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Pancreatic Cancer Non-resectable

China
Xuzhou Medical University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Unknown

Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS

Pancreaticoduodenectomy | Periampullary Carcinoma Resectable

China
National Cancer Institute (NCI)

Terminated

Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Metastatic Pancreatic Cancer | Histologically or Cytologically Confirmed Pancreatic Cancer | Unresectable or Borderline Resectable Pancreatic Cancer

United States
The First Affiliated Hospital of Henan University...

Recruiting

Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Late-stage Resectable Esophageal Squamous Carcinoma

China
Federation Francophone de Cancerologie Digestive

Not yet recruiting

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma. (NEOPREDICT)

Borderline Resectable Pancreatic Ductal Adenocarcinoma

France
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Locally Advanced Resectable Rectal Cancer

China
Shanghai JMT-Bio Inc.

Recruiting

A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer

Resectable HER2-positive Breast Cancer

China
Akeso

Recruiting

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Resectable Colon Cancer | MSI-H/dMMR Colorectal Cancer

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States
University Health Network, Toronto

Active, not recruiting

FAZA PET/MRI Pancreas

Locally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Cancer | Pancreatic Adenocarcinoma Non-resectable

Canada
Delcath Systems Inc.

Unknown

Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Hepatic Malignant Neoplasm Primary Non-Resectable

United Kingdom
Abramson Cancer Center at Penn Medicine

Active, not recruiting

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy | Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy

United States
Amsterdam UMC, location VUmc
University Medical Center Groningen; Maastricht University Medical Center; UMC... and other collaborators

Not yet recruiting

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma (NEODISCO)

Extrahepatic Cholangiocarcinoma | Distal Cholangiocarcinoma | Perihilar Cholangiocarcinoma | Resectable | Borderline Resectable

Netherlands
PsiOxus Therapeutics Ltd

Completed

Mechanism of Action Trial of ColoAd1 (MOA)

Resectable Colon Cancer | Resectable Non-small Cell Lung Cancer | Resectable Bladder Cancer | Resectable Renal Cell Carcinoma

Spain
Assiut University

Unknown

Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach

Periampullary Carcinoma Resectable

Egypt
Centre Hospitalier Universitaire Dijon

Terminated

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours (EOLE)

Non-resectable Metastatic Cancer of the Lung | Non-resectable Metastatic Cancer of the Colon | Non-resectable Metastatic Cancer of the Rectosigmoid Junction | Non-resectable Metastatic Cancer of the Stomach | Non-resectable Metastatic Cancer of the Bile Duct | Non-resectable Metastatic Cancer... and other conditions

France
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand, Switzerland, Netherlands
Asan Medical Center

Active, not recruiting

Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers (NeoChance)

Subjects With Resectable and Localized Gastric Cancer | Subjects With Resectable Esophageal Cancer or Liver Cancer | Subjects With Resectable Liver Cancer

South Korea
Tongji Hospital

Completed

Laparoscopic Pancreatoduodenectomy Versus Open Pancreatoduodenectomy

Resectable Lesions Located in the Pancreatic Head or Periampullary Region
Institut Paoli-Calmettes
Federation Francophone de Cancerologie Digestive

Not yet recruiting

A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) (PRODIGE 104 B)

Pancreatic Cancer Resectable | Pancreas Adenocarcinoma (MSI-H)
CEBIOTEX

Recruiting

CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours (CEB-01-RLP01-C)

Locally Resectable Paediatric Tumours

Spain
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

Resectable Stage II-III Non-small Cell Lung Cancer

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of DNA in Blood Samples From Patients With Neuroblastoma

Recurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma

United States
Weill Medical College of Cornell University

Terminated

RFA RCT for Pancreatic or Bile Duct Cancer (RFARCT)

Cholangiocarcinoma Non-resectable | Unresectable Pancreatic Cancer

United States
Jianxing He
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC (K-NADIR)

Neoadjuvant Therapy | KRAS G12C Mutation | Resectable NSCLC | Stage IB-IIIA NSCLC

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4 Neuroblastoma

United States

Clinical Trials on Resectable

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations